Gene · 7150
Papers4,103
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 4,103
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Why Don't the Mutant Cells That Evade DNA Repair Cause Cancer More Frequently? Importance of the Innate Immune System in the Tumor Microenvironment. | Int J Mol Sci | 2023 | 36902456 | PubTator, text mining | PubMed |
| Does Digitization Promote Green Innovation? Evidence from China. | Int J Environ Res Public Health | 2023 | 36900903 | PubTator, text mining | PubMed |
| DNA Repair Deficiency Regulates Immunity Response in Cancers: Molecular Mechanism and Approaches for Combining Immunotherapy. | Cancers (Basel) | 2023 | 36900418 | PubTator, text mining | PubMed |
| Isogenic Cell Lines Derived from Specific Organ Metastases Exhibit Divergent Cytogenomic Aberrations. | Cancers (Basel) | 2023 | 36900209 | PubTator, text mining | PubMed |
| Circulating Chemerin Is Elevated in Women With Preeclampsia. | Endocrinology | 2023 | 36882076 | PubTator, text mining | PubMed |
| Influence network model uncovers relations between biological processes and mutational signatures. | Genome Med | 2023 | 36879282 | PubTator, text mining | PubMed |
| Lesion Shedding Model: unraveling site-specific contributions to ctDNA. | Brief Bioinform | 2023 | 36869848 | PubTator, text mining | PubMed |
| Genetic requirements for repair of lesions caused by single genomic ribonucleotides in S phase. | Nat Commun | 2023 | 36869098 | PubTator, text mining | PubMed |
| A SARS-CoV-2-specific CAR-T-cell model identifies felodipine, fasudil, imatinib, and caspofungin as potential treatments for lethal COVID-19. | Cell Mol Immunol | 2023 | 36864189 | PubTator, text mining | PubMed |
| Direct visualization of transcription-replication conflicts reveals post-replicative DNA:RNA hybrids. | Nat Struct Mol Biol | 2023 | 36864174 | PubTator, text mining | PubMed |
| Elucidating the potential pharmaceutical mechanism of Gyejibokryeong-hwan on rosacea using network analysis. | Medicine (Baltimore) | 2023 | 36862896 | PubTator, text mining | PubMed |
| Does the CFO serving as the secretary of the board affect the financial statement comparability?-evidence from China. | Heliyon | 2023 | 36851957 | PubTator, text mining | PubMed |
| Bioinformatics Analysis of Next Generation Sequencing Data Identifies Molecular Biomarkers Associated With Type 2 Diabetes Mellitus. | Clin Med Insights Endocrinol Diabetes | 2023 | 36844983 | PubTator, text mining | PubMed |
| The HER2-low revolution in breast oncology: steps forward and emerging challenges. | Ther Adv Med Oncol | 2023 | 36844387 | PubTator, text mining | PubMed |
| Development of a selection assay for small guide RNAs that drive efficient site-directed RNA editing. | Nucleic Acids Res | 2023 | 36840708 | PubTator, text mining | PubMed |
| A Review of Protein- and Peptide-Based Chemical Conjugates: Past, Present, and Future. | Pharmaceutics | 2023 | 36839922 | PubTator, text mining | PubMed |
| Recent Advances in the Development of Nanodelivery Systems Targeting the TRAIL Death Receptor Pathway. | Pharmaceutics | 2023 | 36839837 | PubTator, text mining | PubMed |
| Nanoparticles for Drug and Gene Delivery in Pediatric Brain Tumors' Cancer Stem Cells: Current Knowledge and Future Perspectives. | Pharmaceutics | 2023 | 36839827 | PubTator, text mining | PubMed |
| Emerging Role of Plant-Based Dietary Components in Post-Translational Modifications Associated with Colorectal Cancer. | Life (Basel) | 2023 | 36836621 | PubTator, text mining | PubMed |
| What's on the Other Side of the Gate: A Structural Perspective on DNA Gate Opening of Type IA and IIA DNA Topoisomerases. | Int J Mol Sci | 2023 | 36835394 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7150/papers?page=34